PATIENT RESOURCES
At DACOGEN.com, we’re dedicated to supporting patients and their caregivers. Educational
materials and tools are several ways to help you manage your MDS. In the Patient
Resources section, you can track your MDS symptoms, print your entries, and share
the form with your doctor so you get the care you need. Living with MDS can be difficult,
but DACOGEN.com can help.
Learn about the resources in this section:
DACOGEN is indicated for treatment of patients with myelodysplastic syndromes (MDS),
including previously treated and untreated, de novo, and secondary MDS of all FAB
subtypes (RA, RARS, RAEB, RAEB-t, CMML) and Intermediate-1, Intermediate-2, and
High-Risk IPSS groups.
DACOGEN may cause fetal harm when administered to a pregnant woman. Women of childbearing
potential should be advised to avoid becoming pregnant while using DACOGEN. Men
should be advised not to father a child while receiving treatment with DACOGEN,
and for 2 months afterwards. The most commonly occurring adverse reactions include
neutropenia, thrombocytopenia, anemia, fatigue, pyrexia, nausea, cough, petechiae,
constipation, diarrhea, and hyperglycemia.
DACOGEN is available by prescription only. Please see the important product information
for DACOGEN for more information. This site does not contain everything that is
known about DACOGEN. If you would like to know more, talk to your healthcare professional.